Cochlear (CHEOF) Stock Price, News & Analysis

Company Overview

Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions. Its products are designed for people with severe to profound hearing loss who may not receive sufficient benefit from conventional hearing aids.

The company’s portfolio includes cochlear implants, bone-conduction hearing implants and related sound processors, accessories and connectivity products. Cochlear also provides clinical support, rehabilitation resources and ongoing services for recipients, hearing professionals and healthcare providers.

Founded in 1981 and headquartered in Sydney, Australia, Cochlear grew out of research into the world’s first multichannel cochlear implant. The company serves patients and healthcare markets across a broad international footprint, including Australia, North America, Europe and Asia-Pacific. Its shares trade on the Australian Securities Exchange under the symbol COH, and its American depositary securities trade over the counter under the symbol CHEOF.

Key Stats

• Today's Range: $103.46 to $103.46
• 50-Day Range: $90.37 to $105.41
• 52-Week Range: $64.39 to $197.11
• Volume: N/A
• Average Volume: 1,299 shs
• Market Capitalization: N/A
• P/E Ratio: 63.01
• Dividend Yield: 1.23%
• Price Target: N/A
• Consensus Rating: N/A

Cochlear Stock Analysis - MarketRank™

Cochlear scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cochlear.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cochlear is 63.01, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.41.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cochlear is 63.01, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.71.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cochlear has a short interest ratio ("days to cover") of 298.51, which indicates bearish sentiment.

Change versus previous month

Short interest in Cochlear has recently decreased by 2.25%, indicating that investor sentiment is improving.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Cochlear pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cochlear does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Cochlear is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: N/A

News Sentiment

Cochlear has a news sentiment score of -0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Cochlear this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cochlear insiders have not sold or bought any company stock.

Percentage Held by Institutions

22.47% of the stock of Cochlear is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CHEOF
• CIK: 1453930
• Web: www.cochlear.com
• Phone: (129) 428-6555
• Fax: N/A
• Employees: 5,400
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 63.01
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A